13 Pulmonary Embolism Clinical Trials in Omaha, NE (2026)

Q: How do I join a clinical trial in Omaha?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you.

Recruiting Pulmonary Embolism Studies in Omaha

NCT03568630Recruiting

Blood Markers of Early Pancreas Cancer

Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms a...

Omaha, NE1,250 participantsUniversity of Nebraska

View Study Details

NCT06888011Recruiting

iAmHealthy Clinical Practice Guideline (CPG)

The current study is a multilevel factorial design RCT with interventions at the clinic (Healthy Clinic intervention period vs. Control period) and individual patient levels (iAmHealthy vs. Newsletter...

Omaha, NENA1,024 participantsUniversity of Kansas Medical Center

View Study Details

NCT07023003Recruiting

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

This is an open label, randomized controlled trial designed to compare nifedipine and enalapril in the management of postpartum hypertension. This is an equivalence study- meaning it is not expected o...

Omaha, NEPHASE4850 participantsNebraska Methodist Health System

View Study Details

NCT06940232Recruiting

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

The primary objective of this study is to establish if Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) are predictive of computed tomography (CT) findings in pedi...

Omaha, NE330 participantsUniversity of Nebraska

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

Omaha, NENA206 participantsOlympus Corporation of the Americas

View Study Details

NCT07029828Recruiting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

The purpose of this clinical trial is to learn about long-term safety and long-term effects of the study medicine (called ritlecitinib) for the potential treatment of severe alopecia areata, a conditi...

Omaha, NEPHASE3140 participantsPfizer

View Study Details

NCT07311564Recruiting

A Study of LAD603 in Adults With Alopecia Areata

The main aim of the study is to evaluate the effect of LAD603 in adult participants with severe to very severe alopecia areata (AA). The study will also evaluate the safety, pharmacokinetics (PK), imm...

Omaha, NEPHASE2136 participantsAlmirall, S.A.

View Study Details

NCT06057935Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal m...

Omaha, NEPHASE264 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06389149Recruiting

Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease

The purpose of this study is to test the effects of leg exercise assistive paddling (LEAP) therapy during prolonged sitting (PS) on vascular and functional performance in those with peripheral artery ...

Omaha, NENA24 participantsUniversity of Nebraska

View Study Details

NCT04889716Recruiting

CAR-T Followed by Bispecific Antibodies

The research study is being conducted to test the safety and effectiveness of the experimental drug mosunetuzumab (Cohort 1) or obinutuzumab and glofitamab (Cohort 2) when given after CAR (genetically...

Omaha, NEPHASE223 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT06319339Recruiting

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral artery disease (PAD) is associated with elevated oxidative stress, and oxidative stress has been implicated as the cause of reduced endothelial reactivity in individuals with PAD. Endotheli...

Omaha, NEEARLY_PHASE120 participantsUniversity of Nebraska

View Study Details

NCT06480786Recruiting

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

Peripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results fro...

Omaha, NENA15 participantsUniversity of Nebraska

View Study Details

NCT06003855Recruiting

Oxygen-guided Supervised Exercise Therapy

Peripheral artery disease (PAD) is a cardiovascular disease manifesting from systemic atherosclerosis, which blocks the leg arteries and results in insufficient blood flow to the lower extremities. Li...

Omaha, NENA12 participantsVA Office of Research and Development

View Study Details

About Pulmonary Embolism Clinical Trials in Omaha

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 13 pulmonary embolism clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 4,094 participants. Research is being sponsored by University of Nebraska, University of Kansas Medical Center, Nebraska Methodist Health System and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Omaha — FAQ

Are there pulmonary embolism clinical trials in Omaha?

Yes, there are 13 pulmonary embolism clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Omaha?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.

Are clinical trials in Omaha free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 13 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 19, 2026 from ClinicalTrials.gov